ANG Lifesciences India Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002820,
    "name": "ANG Lifesciences",
    "stock_name": "ANG Lifesciences",
    "full_name": "ANG Lifesciences India Ltd",
    "name_url": "stocks-analysis/ang-lifesciences",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.49",
    "chg": 0.77,
    "chgp": "1.99%",
    "dir": 1,
    "prev_price": "38.72",
    "mcapval": "51.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE236W01016",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "04:41 AM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "2.98 k",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ang-lifesciences-1002820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ANG Lifesciences India Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-downgraded-to-strong-sell-amid-weak-financials-and-mixed-technicals-4201891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ANGLifesciences_mojoScore_4201891.png",
        "date": "2026-09-23 08:21:50",
        "description": "ANG Lifesciences India Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 22 September 2026, reflecting a complex interplay of deteriorating financial fundamentals and mixed technical signals. Despite some positive price momentum over recent months, the company’s weak profitability, high leverage, and subdued long-term prospects have compelled analysts to revise their stance, signalling caution for investors in this micro-cap pharmaceutical stock."
      },
      {
        "title": "ANG Lifesciences India Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4196866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ANGLifesciences_mojoScore_4196866.png",
        "date": "2026-09-18 08:15:20",
        "description": "ANG Lifesciences India Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 17 Sep 2026, driven primarily by improved technical indicators. However, the company’s financial health and valuation metrics remain weak, reflecting ongoing operational challenges and elevated risk for investors."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-4162567",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ANGLifesciences_mojoScore_4162567.png",
        "date": "2026-08-20 10:10:22",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4137938",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ANGLifesciences_mojoScore_4137938.png",
        "date": "2026-08-05 10:10:03",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4115147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ANGLifesciences_mojoScore_4115147.png",
        "date": "2026-07-22 10:10:32",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with the latest insights into the company's performance and outlook."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4096418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ANGLifesciences_mojoScore_4096418.png",
        "date": "2026-07-10 10:10:04",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4077000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ANGLifesciences_mojoScore_4077000.png",
        "date": "2026-06-29 10:10:05",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 313,
    "sid": "1002820",
    "stock_news_url": "https://www.marketsmojo.com/news/ang-lifesciences-india-1002820"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Sep-2026",
      "details": "Intimation of Closure of Trading Window.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of 20Th Annual General Meeting",
      "datetime": "07-Sep-2026",
      "details": "Intimation of 20th Annual General Meeting",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 20Th AGM Of The Company On Wednesday 30Th September 2026 At 12 :00 Noon. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OA VM).",
      "datetime": "07-Sep-2026",
      "details": "Notice of 20th AGM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has declared <strong>10%</strong> dividend, ex-date: 02 Nov 21",
          "dt": "2021-11-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has announced <strong>1:4</strong> bonus issue, ex-date: 13 Jul 22",
          "dt": "2022-07-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

ANG Lifesciences India Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technicals

2026-09-23 08:21:50

ANG Lifesciences India Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 22 September 2026, reflecting a complex interplay of deteriorating financial fundamentals and mixed technical signals. Despite some positive price momentum over recent months, the company’s weak profitability, high leverage, and subdued long-term prospects have compelled analysts to revise their stance, signalling caution for investors in this micro-cap pharmaceutical stock.

Read full news article

ANG Lifesciences India Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-09-18 08:15:20

ANG Lifesciences India Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 17 Sep 2026, driven primarily by improved technical indicators. However, the company’s financial health and valuation metrics remain weak, reflecting ongoing operational challenges and elevated risk for investors.

Read full news article

ANG Lifesciences India Ltd is Rated Strong Sell

2026-08-20 10:10:22

ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-08-05 10:10:03

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-07-22 10:10:32

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with the latest insights into the company's performance and outlook.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-07-10 10:10:04

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-06-29 10:10:05

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News